tradingkey.logo
tradingkey.logo
検索

Bone Biologics Corp

BBLG
ウォッチリストに追加
1.420USD
+0.020+1.43%
終値 07/02, 13:00ET15分遅れの株価
2.55M時価総額
損失額直近12ヶ月PER

詳細情報 Bone Biologics Corp 企業名

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corpの企業情報

企業コードBBLG
会社名Bone Biologics Corp
上場日Nov 27, 2015
最高経営責任者「CEO」Frelick (Jeffrey)
従業員数2
証券種類Ordinary Share
決算期末Nov 27
本社所在地2 Burlington Woods Dr Ste 100
都市BURLINGTON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号01803-4551
電話番号17815524452
ウェブサイトhttps://www.bonebiologics.com/
企業コードBBLG
上場日Nov 27, 2015
最高経営責任者「CEO」Frelick (Jeffrey)

Bone Biologics Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

よくある質問

Bone Biologics Corpの上位5名の株主は誰ですか?

Bone Biologics Corpの上位5名の株主は以下のとおりです。Mr. Jeffrey Frelick

Bone Biologics Corp(BBLG)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bone Biologics Corpの株式を保有している機関は17社あり、保有株式の総市場価値は約58.41Kで、全体の3.25%を占めています。2025Q4と比較して、機関の持ち株は22009.00増加しています。